| Nov 14 |
The Oncology Bet Is Already Paying Off For Pfizer
|
| Nov 12 |
Novavax stock plunges after quarterly earnings, but company sees hope in licensing deals
|
| Nov 12 |
FDA clears Novavax to resume trials of Covid-19 and flu combo vaccine
|
| Nov 12 |
Moderna Tops BioSpace's Best Places to Work Ranking for Fourth Consecutive Year
|
| Nov 11 |
Moderna’s mRESVIA vaccine gains Health Canada approval
|
| Nov 9 |
Earnings Beat: Moderna, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
|
| Nov 9 |
What Moved Markets This Week
|
| Nov 8 |
Moderna's Q3 Earnings Beat Overshadowed By Vaccine Demand Slowdown And Market Share Concerns, Analysts Warn
|
| Nov 8 |
2 Biotech Stocks You Can Buy Hand Over Fist This Month
|
| Nov 8 |
Moderna (MRNA) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
|
